Consolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma. Issue 3 (March 2015)

• Record Type: Journal Article
• Authors: Koechli, Valentin; Klaeser, Bernd; Banz, Yara; Mueller, Beatrice U.; Pabst, Thomas
• Is Part Of: Leukemia research. Volume 39:Issue 3(2015:Mar.)
• Page Start: 307
• Page End: 310
• Publication Date: 2015-03
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2014.12.016
• Languages: English
• ISSNs: 0145-2126

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Radioimmunotherapy consolidation has not been reported in rituximab treated BL.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">In this series, none of 5 BL patients relapsed after Y-90-IT consolidation in CR1.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">OS and PFS in BL patients without or with Y-90-IT were not significant.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">Significant myelosuppression was seen in BL patients after Y-90-IT consolidation.</p> </list-item> </list> </p> </sec> </abstract>